Skip to Main Content

Advertisement

Skip Nav Destination

Correction: Article on the Characterization and Multiparameter Analysis of Visual Adverse Events in Irofulven Single-Agent Phase I and II Trials

Clin Cancer Res (2005) 11 (4): 1684a–1684.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal